Navigation Links
SkilaMederi Names Ray Joske as Chief Commercial Officer
Date:1/31/2013

MORRIS PLAINS, N.J., Jan. 31, 2013 /PRNewswire/ -- Global life sciences strategic advisory and data analytics solutions provider SkilaMederi today announced the appointment of Raymond Joske to its Executive Management Team as Chief Commercial Officer. In this role, Joske will oversee commercial efforts worldwide for SkilaMederi and report directly to CEO Kilian Weiss .

Mr. Joske has more than 28 years of executive experience in the client and support sides of the life sciences industry, including sales, sales management, marketing, new product development, disease management, analytics and market access. At Bristol-Myers Squibb, he held commercial roles in sales management, product marketing and market access. Mr. Joske also served as Senior Vice President of Marketing, Business Development and International Sales and Marketing for a Merck KGaA affiliate, and Senior Vice President of the Healthcare Analytics Group, a division of Gallagher Benefit Services. Before joining SkilaMederi, Mr. Joske oversaw new product development and marketing for MediMedia® Health, a provider of multichannel promotional health care-related campaigns.

"Ray offers the breadth of business development and marketing experience that will advance SkilaMederi's position as a unique life sciences advisory firm that harnesses expert counsel, big data analytics and other knowledge tools to deliver the predictive insight our clients need to achieve a competitive advantage," said SkilaMederi CEO Kilian Weiss . "We look forward to his contribution as SkilaMederi embarks on this next stage of growth."

For more information on SkilaMederi, please visit www.skilamederi.com.

About SkilaMederi
SkilaMederi is a specialized life sciences advisory firm that leverages big data and social network analytics to produce the predictive insight pharmaceutical and bioscience clients need to successfully position, launch and market new products. With deep life sciences industry expertise anchoring comprehensive service offerings, SkilaMederi provides strategic insight, social network analytics and knowledge-based tools distinct from conventional consultancies that offer only a few localized specialists or off-the-shelf software. SkilaMederi's tailored portfolio of strategic and analytics services draws upon its globally-networked subject matter experts and incisive "human crowd-sourced intelligence" data-gathering methods. The strength of those combined assets explains why the world's leading life science organizations turn to SkilaMederi to develop the most productive solutions for the most difficult challenges.

SkilaMederi has offices in the United States, Germany, the United Kingdom, France, and Ukraine.


'/>"/>
SOURCE SkilaMederi
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics names Ann Tobin as Chief Compliance Officer
2. Innovation Names Dr. Phil Samples Vice President, Government & Professional Services
3. Compressus Names Joe Lavelle as COO
4. Sophono Names Global Sales and Marketing Vice President
5. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
6. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
7. Alimera Sciences Names European Management Team
8. 2012 Facility of the Year Awards Program Names Mercks Vaccine Bulk Manufacturing Facility (VBF) Program of Projects as Overall Winner
9. Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
10. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
11. Beckers Hospital Review Names 100 Hospitals With Great Womens Health Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan 18, 2017 Research and Markets ... by Product, by End User - Global Opportunity Analysis and Industry Forecast, ... ... 2015 and is expected to reach $5,491 million by 2022, growing at ... North America was the leading regional market in global ...
(Date:1/18/2017)... SAN JOSE, Calif. , Jan. 18, 2017  Adaptive ... machines, announced today a new partnership with Hyatt Place ... guests by providing ASTI LectroFan sleep therapy machines in ... "Obviously one of the most important parts of having ... Wicks , general manager of Hyatt Place Nashville/Downtown. "We,re ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... company specializing in the development and commercialization of regenerative ... and organs, recently reported the Company,s operating results for ... As the Company described in its recent ... year of substantial accomplishments. The Company,s contract laboratory completed ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Students interested in video can get a jump start on ... earn a $1,000 scholarship and have his or her video posted on the GenCure ... May 31, with the winner announced on June 9. , The competition is designed ...
(Date:1/19/2017)... PA (PRWEB) , ... January 19, 2017 , ... Allegheny ... experience of patients who seek access to the Network’s programs and services in the ... primary or specialty care appointments will be offered one for that same afternoon. ...
(Date:1/19/2017)... ... January 19, 2017 , ... For ... serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity ... (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, is ...
(Date:1/19/2017)... ... 2017 , ... For the second consecutive year, all five ... have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, Dr. Joshua ... by their peers for the 2017 list based on their exceptional patient care ...
(Date:1/19/2017)... ... , ... The 21st Century Cures Act’s Impact on Medical Devices:, What You ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do ... this year? , The passage of the act means devicemakers will be scrambling to ...
Breaking Medicine News(10 mins):